PRENETICS GLOBAL LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.76 USD | -1.37% |
|
-0.76% | -2.54% |
| May. 21 | Prenetics Global Limited Announces Committee Resignations | CI |
| Apr. 01 | Prenetics Global Limited Reports Impairment Loss of Goodwill for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | - | 222 | 71.03 | 70.37 | - |
| Enterprise Value (EV) 1 | - | 222 | 71.03 | 70.37 | 70.37 |
| P/E ratio | -0.83 x | -0.8 x | -1.06 x | -1.6 x | -7.78 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 0.8 x | 3.27 x | 2 x | 0.78 x |
| EV / Revenue | - | 0.8 x | 3.27 x | 2 x | 0.78 x |
| EV / EBITDA | - | 3,806,278 x | - | - | - |
| EV / FCF | - | - | - | - | - |
| FCF Yield | - | - | - | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | - | 7,399 | 12,018 | 12,217 | - |
| Reference price 2 | 115.2 | 30.00 | 5.910 | 5.760 | 5.760 |
| Announcement Date | 4/11/22 | 3/14/23 | 5/1/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | - | 275.8 | 21.74 | 35.2 | 90 |
| EBITDA | - | 58.31 | - | - | - |
| EBIT 1 | - | -23.3 | -51.91 | -47 | -12.6 |
| Operating Margin | - | -8.45% | -238.73% | -133.52% | -14% |
| Earnings before Tax (EBT) 1 | - | -183.3 | -56.67 | -47 | -12.6 |
| Net income 1 | -174 | -190.5 | -62.72 | -47 | -10.4 |
| Net margin | - | -69.06% | -288.48% | -133.52% | -11.56% |
| EPS 2 | -138.6 | -37.50 | -5.580 | -3.590 | -0.7400 |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/11/22 | 3/14/23 | 5/1/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 92.04 | 51.72 | 79.68 | 52.32 | 17.7 | 5.696 | 4.866 | 5.277 | 6.2 | 7.7 | 9.2 | 12.1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | -0.5507 | -17.9 | -9.485 | 4.63 | -12.04 | -12.17 | -13.68 | -11.46 | -12.6 | -12.3 | -11.8 | -10.3 |
| Operating Margin | -0.6% | -34.61% | -11.9% | 8.85% | -68.05% | -213.6% | -281.07% | -217.24% | -203.23% | -159.74% | -128.26% | -85.12% |
| Earnings before Tax (EBT) 1 | -31.32 | -143.9 | -11.4 | 3.323 | -10.98 | -15.78 | -12.74 | -18.58 | -12.6 | -12.3 | -11.8 | -10.3 |
| Net income 1 | -32.99 | -144.2 | -14.9 | 1.608 | -10.4 | -21.81 | -13.57 | -16.95 | -12.6 | -12.3 | -11.8 | -10.3 |
| Net margin | -35.84% | -278.78% | -18.7% | 3.07% | -58.75% | -382.89% | -278.91% | -321.17% | -203.23% | -159.74% | -128.26% | -85.12% |
| EPS 2 | -33.15 | -20.40 | -3.150 | 0.1500 | -1.050 | -2.100 | -1.200 | -5.300 | -1.020 | -0.9600 | -0.8900 | -0.7500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 6/6/22 | 9/9/22 | 11/10/22 | 3/14/23 | 6/5/23 | 9/15/23 | 11/20/23 | 5/1/24 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | 4.95 | - | - | - |
| Capex / Sales | - | 1.79% | - | - | - |
| Announcement Date | 4/11/22 | 3/14/23 | 5/1/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.76
USD
Average target price
9
USD
Spread / Average Target
+56.25%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.54% | 70.37M | |
| -32.63% | 9.2B | |
| -5.66% | 3.12B | |
| +23.12% | 2.8B | |
| -18.33% | 2.05B | |
| -24.39% | 1.59B | |
| +65.65% | 1.44B | |
| +32.83% | 830M | |
| -6.77% | 720M | |
| -29.80% | 507M |
- Stock Market
- Equities
- PRE Stock
- Financials Prenetics Global Limited
